Zobrazeno 1 - 10
of 39
pro vyhledávání: '"E. Samarkina"'
Autor:
Yulia E. Samarkina
Publikováno v:
Теория и практика общественного развития. :149-152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::544207c0d19416935a91dada917f655f
https://doi.org/10.24158/tipor.2023.2.21
https://doi.org/10.24158/tipor.2023.2.21
Publikováno v:
Annals of the Rheumatic Diseases. 81:1273.1-1273
BackgroundMuscle health is an important aspect of rheumatoid arthritis (RA). A decrease in muscle mass and physical performance is a frequent complication of RA that contributes to inability to work and reduced quality of life. Vitamin D deficiency i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a82fff77ac0139182618328d04fb3a59
https://doi.org/10.1136/annrheumdis-2022-eular.3392
https://doi.org/10.1136/annrheumdis-2022-eular.3392
Publikováno v:
Annals of the Rheumatic Diseases. 81:1736.2-1737
BackgroundSystemic juvenile idiopathic arthritis (sJIA) is a childhood arthritis with signs of autoinflammation and high risk of macrophage activation syndrome (MAS). Immunopathogenesis of sJIA is based on excessive activation of innate immunity, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a13bebe4d951a842b78ae1eb5237037
https://doi.org/10.1136/annrheumdis-2022-eular.3328
https://doi.org/10.1136/annrheumdis-2022-eular.3328
Publikováno v:
Annals of the Rheumatic Diseases. 81:1188.1-1189
BackgroundThromboinflammation is a pathological process that is associated with uncontrolled inflammation, leading to hypercoagulability and thrombotic complications. Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are prototyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cd6a7b2baa6b45f37ca2980c393f907
https://doi.org/10.1136/annrheumdis-2022-eular.1331
https://doi.org/10.1136/annrheumdis-2022-eular.1331
Autor:
E. Taskina, L. Alekseeva, N. Kashevarova, K. Telyshev, D. Kudinsky, N. Demin, O. Alekseeva, M. Cherkasova, E. Samarkina, E. Strebkova, E. Sharapova, F. Bibulatova, O. Tenkova, A. Aboleshina, E. Kharlamova, T. Raskina, J. Averkieva, E. Usova, I. Vinogradova, O. Salnikova, E. Otteva, A. Lila
Publikováno v:
Annals of the Rheumatic Diseases. 81:1622.2-1623
Objectivesto outline specific biochemical and imaging features of metabolic phenotype of knee osteoarthritis (OA) in a multicenter prospective study.Methods284 female patients with knee OA (according to the ACR criteria) aged 40-78 were included in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2448b14c87587ef0cf3056e47aa866b
https://doi.org/10.1136/annrheumdis-2022-eular.4242
https://doi.org/10.1136/annrheumdis-2022-eular.4242
Publikováno v:
Annals of the Rheumatic Diseases. 81:1321.1-1321
BackgroundThe key link in the therapeutic drug monitoring of methotrexate (MTX) is the measurement of the concentrations of its most stable metabolites, as well as products of the early and late stages of MTX conversion (short-chain polyglutamates).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8aababa8d78b41babea48a6543cdad6
https://doi.org/10.1136/annrheumdis-2022-eular.534
https://doi.org/10.1136/annrheumdis-2022-eular.534
Publikováno v:
Annals of the Rheumatic Diseases. 80:1040.1-1040
Background:Ankylosing spondylitis is a chronic systemic inflammatory disease. Inflammation and high levels of serum amyloid A (SAA) protein are predisposing factors for secondary AA amyloidosis. The role of SAA1 gene polymorphisms in AS is not well u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::520e8d398793fc9cdfa8df747b1e0258
https://doi.org/10.1136/annrheumdis-2021-eular.2998
https://doi.org/10.1136/annrheumdis-2021-eular.2998
Autor:
G. Gridneva, Y. Muraviev, Anna V. Kudryavtseva, N. Baymeeva, E. Samarkina, Svetlana Glukhova, V. Sygyrta, E. Aronova
Publikováno v:
Annals of the Rheumatic Diseases. 80:1158.1-1158
Background:7-hydroxy Methotrexate (7-hydroxy-MTX) is a phase I metabolite of MTX, which is converted by hepatic aldehyde oxidases. It is known that 7-hydroxy MTX can reduce the effectiveness of methotrexate, which is associated with increased excreti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a8cbf75a918698ace07fd3fd356304e
https://doi.org/10.1136/annrheumdis-2021-eular.2276
https://doi.org/10.1136/annrheumdis-2021-eular.2276
Autor:
Anna V. Kudryavtseva, Alexander Lila, G. Gridneva, V. Sygyrta, Y. Muraviev, E. Samarkina, N. Baymeeva, E. Aronova
Publikováno v:
Annals of the Rheumatic Diseases. 80:465.2-465
Background:Studying the dynamics of the methotrexate metabolites concentration in cells will help to predict the therapeutic effect and assess patient compliance. We suggest that studying the dynamics of changes in the concentration of methotrexate m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19c7988f98184a3e08132a03f8ae959e
https://doi.org/10.1136/annrheumdis-2021-eular.2351
https://doi.org/10.1136/annrheumdis-2021-eular.2351
Publikováno v:
Annals of the Rheumatic Diseases. 80:243.2-243
Background:Autoinflammatory diseases (AIDs) are a group of rare, genetically determined diseases characterized by a periodic events of inflammation, fever, and clinical symptoms that mimic rheumatic pathology. Laboratory serological markers of AIDs a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d64c8111da90c392b6ad3cd71946dd0
https://doi.org/10.1136/annrheumdis-2021-eular.3910
https://doi.org/10.1136/annrheumdis-2021-eular.3910